These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 24572053)

  • 1. Spending of HIV resources in Asia and Eastern Europe: systematic review reveals the need to shift funding allocations towards priority populations.
    Craig AP; Thein HH; Zhang L; Gray RT; Henderson K; Wilson D; Gorgens M; Wilson DP
    J Int AIDS Soc; 2014; 17(1):18822. PubMed ID: 24572053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing HIV/AIDS resources in Armenia: increasing ART investment and examining HIV programmes for seasonal migrant labourers.
    Kelly SL; Shattock AJ; Kerr CC; Stuart RM; Papoyan A; Grigoryan T; Hovhannisyan R; Grigoryan S; Benedikt C; Wilson DP
    J Int AIDS Soc; 2016; 19(1):20772. PubMed ID: 27281790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies.
    Gomez GB; Borquez A; Case KK; Wheelock A; Vassall A; Hankins C
    PLoS Med; 2013; 10(3):e1001401. PubMed ID: 23554579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Option B+ for the prevention of mother-to-child transmission of HIV infection in developing countries: a review of published cost-effectiveness analyses.
    Karnon J; Orji N
    Health Policy Plan; 2016 Oct; 31(8):1133-41. PubMed ID: 27016949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework.
    Bautista-Arredondo S; Gadsden P; Harris JE; Bertozzi SM
    AIDS; 2008 Jul; 22 Suppl 1():S67-74. PubMed ID: 18664956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allocative and implementation efficiency in HIV prevention and treatment for people who inject drugs.
    Benedikt C; Kelly SL; Wilson D; Wilson DP;
    Int J Drug Policy; 2016 Dec; 38():73-80. PubMed ID: 27883944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Financing the response to HIV in low-income and middle-income countries.
    Izazola-Licea JA; Wiegelmann J; Arán C; Guthrie T; De Lay P; Avila-Figueroa C
    J Acquir Immune Defic Syndr; 2009 Dec; 52 Suppl 2():S119-26. PubMed ID: 19901624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmes, resources, and needs of HIV-prevention nongovernmental organizations (NGOs) in Africa, Central/Eastern Europe and Central Asia, Latin America and the Caribbean.
    Kelly JA; Somlai AM; Benotsch EG; Amirkhanian YA; Fernandez MI; Stevenson LY; Sitzler CA; McAuliffe TL; Brown KD; Opgenorth KM
    AIDS Care; 2006 Jan; 18(1):12-21. PubMed ID: 16282071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of studies assessing the costs and consequences of interventions to reduce mother-to-child HIV transmission in sub-Saharan Africa.
    Scotland GS; van Teijlingen ER; van der Pol M; Smith WC
    AIDS; 2003 May; 17(7):1045-52. PubMed ID: 12700455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost and cost-effectiveness of gender-responsive interventions for HIV: a systematic review.
    Remme M; Siapka M; Vassall A; Heise L; Jacobi J; Ahumada C; Gay J; Watts C
    J Int AIDS Soc; 2014; 17(1):19228. PubMed ID: 25373519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using eHealth to engage and retain priority populations in the HIV treatment and care cascade in the Asia-Pacific region: a systematic review of literature.
    Purnomo J; Coote K; Mao L; Fan L; Gold J; Ahmad R; Zhang L
    BMC Infect Dis; 2018 Feb; 18(1):82. PubMed ID: 29454322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of HIV prevention for high-risk groups at scale: an economic evaluation of the Avahan programme in south India.
    Vassall A; Pickles M; Chandrashekar S; Boily MC; Shetty G; Guinness L; Lowndes CM; Bradley J; Moses S; Alary M; ; Vickerman P
    Lancet Glob Health; 2014 Sep; 2(9):e531-e540. PubMed ID: 25304420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optima TB: A tool to help optimally allocate tuberculosis spending.
    Goscé L; Abou Jaoude GJ; Kedziora DJ; Benedikt C; Hussain A; Jarvis S; Skrahina A; Klimuk D; Hurevich H; Zhao F; Fraser-Hurt N; Cheikh N; Gorgens M; Wilson DJ; Abeysuriya R; Martin-Hughes R; Kelly SL; Roberts A; Stuart RM; Palmer T; Panovska-Griffiths J; Kerr CC; Wilson DP; Haghparast-Bidgoli H; Skordis J; Abubakar I
    PLoS Comput Biol; 2021 Sep; 17(9):e1009255. PubMed ID: 34570767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence.
    Creese A; Floyd K; Alban A; Guinness L
    Lancet; 2002 May; 359(9318):1635-43. PubMed ID: 12020523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sub-national HIV epidemic appraisal in Kenya: a new approach for identifying priority geographies, populations and programmes for optimizing coverage for HIV prevention.
    Banadakoppa Manjappa R; Bhattacharjee P; Shaw SY; Gitonga J; Kioko J; Songok F; Emmanuel F; Arimi P; Musyoki H; Masha RL; Blanchard J
    J Int AIDS Soc; 2024 Jul; 27 Suppl 2(Suppl 2):e26245. PubMed ID: 38982894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National and provincial estimated costs and cost effectiveness of a programme to reduce mother-to-child HIV transmission in South Africa.
    Wilkinson D; Floyd K; Gilks CF
    S Afr Med J; 2000 Aug; 90(8):794-8. PubMed ID: 11022629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the cost of providing a prevention of mother-to-child transmission of HIV/AIDS service in Ethiopia: urban-rural health facilities setting.
    Zegeye EA; Mbonigaba J; Kaye S; Johns B
    BMC Health Serv Res; 2019 Mar; 19(1):148. PubMed ID: 30841870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.
    Johnson WD; Diaz RM; Flanders WD; Goodman M; Hill AN; Holtgrave D; Malow R; McClellan WM
    Cochrane Database Syst Rev; 2008 Jul; (3):CD001230. PubMed ID: 18646068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost and cost-effectiveness of HIV/AIDS prevention strategies in developing countries: is there an evidence base?
    Walker D
    Health Policy Plan; 2003 Mar; 18(1):4-17. PubMed ID: 12582104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prioritization of prevention activities to combat the spread of HIV/AIDS in resource constrained settings: a cost-effectiveness analysis from Chad, Central Africa.
    Hutton G; Wyss K; N'Diékhor Y
    Int J Health Plann Manage; 2003; 18(2):117-36. PubMed ID: 12841152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.